Comparison of F-18 FDG Radioacitivity to Determine Accurate Dose Calibrator Activity Measurements

방사능 측정기를 이용한 F-18 FDG 방사능의 비교

  • Jin, Gye-Hwan (Department of Radiologic Science, Nambu University) ;
  • Kweon, Dae-Cheol (Department of Radiologic Science, Shinheung College University) ;
  • Oh, Ki-Baek (Department of Nuclear Medicine, Severance Hospital, Yonsei University Medical Center) ;
  • Park, Hoon-Hee (Department of Nuclear Medicine, Severance Hospital, Yonsei University Medical Center) ;
  • Kim, Jung-Yul (Department of Nuclear Medicine, Severance Hospital, Yonsei University Medical Center) ;
  • Park, Min-Soo (Department of Nuclear Medicine, Severance Hospital, Yonsei University Medical Center) ;
  • Park, Dae-Sung (Heart Research Center, Chonnam National University Hospital)
  • 진계환 (남부대학교 방사선학과) ;
  • 권대철 (신흥대학 방사선과) ;
  • 오기백 (연세의료원 세브란스병원 핵의학과) ;
  • 박훈희 (연세의료원 세브란스병원 핵의학과) ;
  • 김정열 (연세의료원 세브란스병원 핵의학과) ;
  • 박민수 (연세의료원 세브란스병원 핵의학과) ;
  • 박대성 (전남대학교병원 심장질환 치료기술 개발 특성화 연구센터)
  • Published : 2009.09.30

Abstract

Obviously, the administration of the prescribed amount of activity to the patient requires proper operation of the dose calibrator, which shall be verified by implementing the required quality control on the instrument. This investigation examined the accuracy and precision of dose calibrator activity measurement of the radiopharmaceutical F-18 FDG. To investigate the status of the nuclear medicine centers in Korea for the performance of dose calibrators, 10 centers providing PET/CT system services in Korea were inspected in 2008. We measured accuracy and precision in 10 equipments in consideration of PET/CT model, installation area, and installation time. According to the results of comparative analysis of 10 dose calibrators used to measure radioactivity of F-18 FDG, accuracy was -5.00~4.50% and precision was 0.05~0.45%, satisfying the international standards, which are accuracy ${\pm}$10% and precision ${\pm}$5%. This study demonstrated that, for accurate measurements, no adjustment is necessary for a dose calibrator setting when measuring different dose calibrators of F-18 FDG activity prescriptions.

국내병원에 설치된 PET와 PET/CT의 영상품질관리와 방사능 피폭을 효과적으로 관리하기 위해서는 환자에게 투여하는 F-18 FDG 방사능 측정에 사용하는 방사능 측정기에 따른 정도관리가 필요하다. F-18 FDG의 정확도와 정밀도를 방사능 측정기로 방사능을 측정하기 위해 시료제조 및 방사능을 측정하였다. F-18 FDG의 방사능 측정에 사용하는 방사능 측정기의 정확도와 정밀도를 파악하여 방사능 측정기에서 측정한 방사능을 보정하였다. 국내 의료기관의 PET 시스템 10대를 시간간격으로 측정하여 한국표준과학원에서 측정한 방사능을 기준 값으로 병원에서 측정한 방사능과 비교하여 정확도와 정밀도를 산출하였다. 정확도를 이용하여 팬텀에 주입하는 방사능을 보정함으로써 팬텀에 주입하는 방사능량에 대한 신뢰성을 확보하였다. F-18 FDG의 방사능 측정기의 정확도는 -5.00%에서 +4.50%, 정밀도 0.05%에서 0.45%으로 국제기준인 정확도 ${\pm}$10%, 정밀도 ${\pm}$5%를 모두 만족하였다. PET/CT 시스템들에 대한 정량적 비교 분석 자료는 PET/CT의 진단율을 높이는 효과가 기대된다.

Keywords

References

  1. Antoch G, Saoudi N, Kuehl H, et al: Accuracy of wholebody dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDGPET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22:4357-4368 (2004) https://doi.org/10.1200/JCO.2004.08.120
  2. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK: PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575-581 (2002) https://doi.org/10.1148/radiol.2252011568
  3. Lardinois D, Weder W, Hany TF, et al: Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500-2507 (2003) https://doi.org/10.1056/NEJMoa022136
  4. Lee JH, Kim JS: A Case of Incidentally Detected nasopharyngeal Tuberculosis on F-18 FDG PET/CT. Nucl Med Mol Imaging 42:482-484 (2008)
  5. Lee HJ, Jeong JM, Lee YS, et al: Quality control of residual solvents in [$^{18}$F]FDG preparations by gas chromatography. Nucl Med Mol Imaging 41:566-569 (2007)
  6. Hung JC: Comparison of various requirements of the quality assurance procedures for (18)F-FDG injection. J Nucl Med 43:1495-1506 (2002)
  7. Son HK, Kim HJ, Jung HJ, et al: A study of quality control of nuclear medicine counting system and gamma camera. Korean J Med Phys 12:103-112 (2001)
  8. IAEA International atomic energy agency, quality assurance for radioactivity measurement in nuclear medicine. IAEA technical reports series No.454, IAEA, Vienna (2006)
  9. Taylor JR: An introduction to error analysis: the study of uncertainties in physical measurements. University Science Books, Sausalito, CA (1999), pp. 128-129 (1999)
  10. Ryu JS: Evaluation of cancer treatment using FDG-PET. Korean J Nucl Med 36:64-73 (2002)
  11. Nguyen XC, Lee WW, Sung SW, et al: Prognostic usefulness of maximum standardized uptake value on FDG-PET in surgically resected non-small-cell lung cancer. Nucl Med Mol Imaging 40:205-210 (2006)
  12. Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW: Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology 212:799-802 (1999)
  13. Hubner KF, Thie JA, Smith GT, Chan AC, Fernandez PS, McCoy JM: Clinical utility of FDG-PET in detecting head and neck tumors; a comparison of diagnostic methods and modalities. Clinical Positron Imaging 3:7-16 (2000) https://doi.org/10.1016/S1095-0397(99)00112-0
  14. Rege S, Safa AA, Chaiken L, Hoh C, Juillard G, Withers HR: Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 23:164-169 (2000) https://doi.org/10.1097/00000421-200004000-00012
  15. O'Farrell C, Zimmer1 M, McDonald N, Spies S: Accuracy of the F-18 calibration setting with a Capintec dose calibrator. J Nucl Med 49(Suppl 1):435 (2008)
  16. Mo L, Reinhard MI, Davies JB, Alexiev D, Baldock C: Calibration of the Capintec CRC-712M dose calibrator for (18)F. Appl Radiat Isot 64:485-489 (2006) https://doi.org/10.1016/j.apradiso.2005.09.006
  17. Dansereau RN, Methe BM: Dose variance associated with calibration and administration of radiopharmaceuticals. Am J Health Syst Pharm 58:580-584 (2001)
  18. Lee BI: Quality assurance and performance evaluation of PET/CT. Nucl Med Mol Imaging 42:137-144 (2008)
  19. European Pharmacopoeia, European directorate for the quality of medicines. 4. EDQM, Strasbourg (2001)